Godavari Drugs Ltd vs Phaarmasia Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Godavari Drugs Ltd is ₹ 123.32 as of 30 Apr 15:30 . The P/E Ratio of Godavari Drugs Ltd changed from 8.4 on March 2021 to 15 on March 2025 . This represents a CAGR of 12.30% over 5 yearsThe P/E Ratio of Phaarmasia Ltd changed from 54 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Godavari Drugs Ltd changed from ₹ 34.45 crore on March 2021 to ₹ 65.86 crore on March 2025 . This represents a CAGR of 13.84% over 5 yearsThe Market Cap of Phaarmasia Ltd changed from ₹ 16.97 crore on March 2021 to ₹ 20.02 crore on March 2025 . This represents a CAGR of 3.36% over 5 years The revenue of Godavari Drugs Ltd for the Jun '25 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 22.45 crore. This represent the decline of -100% The revenue of Phaarmasia Ltd for the Jun '25 is ₹ 7.19 crore as compare to the Dec '25 revenue of ₹ 35.21 crore. This represent the decline of -79.58% The ebitda of Godavari Drugs Ltd for the Jun '25 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 2.75 crore. This represent the decline of -100% The ebitda of Phaarmasia Ltd for the Jun '25 is ₹ 0.4 crore as compare to the Dec '25 ebitda of ₹ 19.99 crore. This represent the decline of -98% The net profit of Godavari Drugs Ltd changed from ₹ 1.63 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Phaarmasia Ltd changed from ₹ 0.28 crore to ₹ 0.27 crore over 7 quarters. This represents a CAGR of -2.06% The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Phaarmasia Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.

About Phaarmasia Ltd

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai.
M/s Phaarmasia Limited Unit-II was established in 1993-94.
The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission.
Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

FAQs for the comparison of Godavari Drugs Ltd and Phaarmasia Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or Phaarmasia Ltd?

Market cap of Godavari Drugs Ltd is 124 Cr while Market cap of Phaarmasia Ltd is 67 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and Phaarmasia Ltd?

The stock performance of Godavari Drugs Ltd and Phaarmasia Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and Phaarmasia Ltd?

As of May 4, 2026, the Godavari Drugs Ltd stock price is INR ₹123.32. On the other hand, Phaarmasia Ltd stock price is INR ₹98.16.

How do dividend payouts of Godavari Drugs Ltd and Phaarmasia Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and Phaarmasia Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.